<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: RPC News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=rpc</link><description>Latest Financial News for RADIENT PHARM CP</description><language>en-us</language><lastBuildDate>Mon, 28 Dec 2009 22:37:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Radient Pharmaceuticals Informed by AMEX of Possible Delisting (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091228/0572636.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3710922811</guid><pubDate>Mon, 28 Dec 2009 22:37:00 Etc/GMT</pubDate></item><item><title>RADIENT PHARMACEUTICALS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091228/rpc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1542769549</guid><pubDate>Mon, 28 Dec 2009 21:30:28 Etc/GMT</pubDate></item><item><title>Radient Pharmaceuticals Announces 2010 Business Plans for Its AMDL Diagnostics Subsidiary (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091222/0571832.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2373960658</guid><pubDate>Tue, 22 Dec 2009 17:44:00 Etc/GMT</pubDate></item><item><title>Radient Pharmaceuticals Expands Distribution Partnership With GenWay Biotech to Penetrate Highly Strategic International Markets With Its Onko-Sure Cancer Test (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091221/0571265.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3080451163</guid><pubDate>Mon, 21 Dec 2009 14:03:00 Etc/GMT</pubDate></item><item><title>Radient Pharmaceuticals Chinese Pharma Division Has Put in Place a Strategic Advisory Agreement With Security Research Associates to Assist With the Sale or Financing of Jade Pharmaceutical (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091218/0570527.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2003753673</guid><pubDate>Fri, 18 Dec 2009 14:02:00 Etc/GMT</pubDate></item><item><title>RADIENT PHARMACEUTICALS CORP Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obl (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091216/rpc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/612099930</guid><pubDate>Wed, 16 Dec 2009 21:35:31 Etc/GMT</pubDate></item><item><title>AMDL, INC. - Interview With Douglas C. Maclellan, Chairman And CEO (Wall Street Transcript)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091209/amdl1.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1857415798</guid><pubDate>Wed, 9 Dec 2009 15:43:00 Etc/GMT</pubDate></item><item><title>Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Reimbursement for Its Onko-Sure(TM) in Vitro Diagnostic Cancer Test (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091203/0565558.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3775555993</guid><pubDate>Thu, 3 Dec 2009 19:17:00 Etc/GMT</pubDate></item><item><title>Radient Pharmaceutical Corporation&apos;s CEO &amp; Chairman Mr. Douglas MacLellan Featured on &quot;The Money Channel&apos;s American Scene Radio&quot; (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091202/0565273.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1616919234</guid><pubDate>Thu, 3 Dec 2009 00:37:00 Etc/GMT</pubDate></item><item><title>RADIENT PHARMACEUTICALS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091202/rpc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3355565609</guid><pubDate>Wed, 2 Dec 2009 22:15:19 Etc/GMT</pubDate></item><item><title>UPDATE: Radient Pharma Completes Registered Direct Offering for Approximately $1 Million (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091130/0564241.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1772524082</guid><pubDate>Tue, 1 Dec 2009 03:35:00 Etc/GMT</pubDate></item><item><title>Radient Pharma Completes Registered Direct Offering for Approximately $1 Million (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091130/0564085.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1925194868</guid><pubDate>Mon, 30 Nov 2009 22:30:00 Etc/GMT</pubDate></item><item><title>Radient Pharmaceuticals Reschedules Third Quarter 2009 Earnings Conference Call to Thursday December 3, 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091130/0563969.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1061069186</guid><pubDate>Mon, 30 Nov 2009 19:59:00 Etc/GMT</pubDate></item><item><title>RADIENT PHARMACEUTICALS CORP Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=rpc</link><description></description><guid isPermaLink="false">yahoo_finance/2370584853</guid><pubDate>Sat, 28 Nov 2009 18:04:27 Etc/GMT</pubDate></item><item><title>Radient Pharmaceuticals Announces Third Quarter 2009 Financial Results (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091124/0562543.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/630061198</guid><pubDate>Tue, 24 Nov 2009 16:39:00 Etc/GMT</pubDate></item><item><title>RADIENT PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091123/rpc10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/3308702962</guid><pubDate>Mon, 23 Nov 2009 22:15:40 Etc/GMT</pubDate></item><item><title>Radient Pharmaceuticals Files Extension for Third Quarter 2009 Financial Results (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091116/0559920.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3981382250</guid><pubDate>Tue, 17 Nov 2009 01:36:00 Etc/GMT</pubDate></item><item><title>Radient Pharmaceuticals Signs Research Collaboration Agreement With CeTeCancer (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091015/0547734.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3757315226</guid><pubDate>Thu, 15 Oct 2009 10:02:00 Etc/GMT</pubDate></item><item><title>AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091008/la89313.html?.v=1</link><description>Radient Pharmaceuticals Corporation , a US-based pharmaceutical company through its wholly-owned subsidiary AMDL Diagnostics, Inc. announced today it has entered into an exclusive 5-year marketing and distribution agreement with Grifols USA, LLC.</description><guid isPermaLink="false">yahoo_finance/2232470074</guid><pubDate>Thu, 8 Oct 2009 13:30:00 Etc/GMT</pubDate></item><item><title>Radient Pharma Enters Into Distribution Agreement to Launch Sales of Onko-Sure(TM) IVD Cancer Test in Israel (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091006/la87644.html?.v=1</link><description>Radient Pharmaceuticals Corporation , a US-based pharmaceutical company, announced today through its wholly-owned subsidiary AMDL Diagnostics, Inc. , it has entered into a two-year distribution agreement with Tarom Applied Technologies Ltd. for the marketing and sales of its Onko-Sure in vitro diagnostic cancer test.</description><guid isPermaLink="false">yahoo_finance/63651303</guid><pubDate>Tue, 6 Oct 2009 13:30:00 Etc/GMT</pubDate></item></channel></rss><!-- c6.finance.sp2.yahoo.com compressed/chunked Mon Dec 28 22:44:47 PST 2009 -->
